Foreword

Clinical Drug Investigation

Volumn 31, Issue SUPPL. 1, 2011, Pages 1-3

  Lader, Malcolm ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; SEROTONIN UPTAKE INHIBITOR;

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BODY WEIGHT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; COMORBIDITY; DEPRESSION; DOPAMINERGIC ACTIVITY; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; HUMAN; IMPOTENCE; MONOTHERAPY; ORGASM DISORDER; PRIORITY JOURNAL; SEASONAL AFFECTIVE DISORDER; SIDE EFFECT; SMOKING CESSATION;

EID: 80054875633     PISSN: 11732563     EISSN: 11791918     Source Type: Journal    
DOI: 10.2165/11596410-000000000-00000     Document Type: Editorial

References (10)

1. Qaseem A, Snow V, Denberg TD, et al. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Ann Int Med 2008; 149 (10): 725-33
2. Cipriani A, Furukawa TA, Salanti G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple treatments meta-analysis. Lancet 2009; 373: 747-58
3. Tonnesen P, Tonstad S, Hjalmarson A, et al. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation. J Intern Med 2003; 254 (2): 184-92 (Pubitemid 36900442)
4. Emmanuel NP, Brawman-Mintzer O, Morton WA, et al. Bupropion-SR in treatment of social phobia. Depression Anxiety 2000; 12 (2): 111-13
5. Cantwell DP. ADHD through the life span: the role of bupropion in treatment. J Clin Psychiatry 1998; 59 Suppl 4: 92-4 (Pubitemid 28169264)
6. Stahl S, Pradko J, Haight B, et al. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004; 6 (4): 159-66
7. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005; 142 (7): 532-46
8. Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol 2009; 29 (3): 259-66
9. Crenshaw TL, Goldberg JP, Stern WC. Pharmacologic modification of psychosexual dysfunction. J Sex Marital Ther 1987; 13 (4): 239-52
10. FDA, US National Library of Medicine, National Institutes of Health, Exhibit 4-3: Abuse Potential of Common Psychiatric Medications. Accessed April 28, 2011